This analysis concluded that ACSL1 was upregulated in CRC but diminished in lung and breast cancer, as well as in the brain, cervical, esophageal, head and neck, leukemia, liver, and sarcoma cancers. The gene discussed is ACSL1; the disease is colorectal carcinoma.